Increased invasion of neuroglioma cells transfected with urokinase plasminogen activator receptor cDNA

International Journal of Oncology

Volumn 13, Issue 6, 1998, Pages 1285-1290

  Mohanam, Sanjeeva ^a   Chintala, Shravan K ^a   Mohan, Pamarthi M ^a   Sawaya, Raymond ^a   Lagos, George K ^a   Gokaslan, Ziya L ^a   Kouraklis, Gregory P ^a   Rao, Jasti S ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Gliomas; Invasion; Urokinase plasminogen activator receptor

Indexed keywords

COMPLEMENTARY DNA; MATRIGEL; MESSENGER RNA; UROKINASE RECEPTOR;

ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER INVASION; CELL CULTURE; CHEMOTAXIS; DNA TRANSFECTION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GLIOMA; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; TUMOR CELL CULTURE; ZYMOGRAPHY;

EID: 0031772071     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.6.1285     Document Type: Article

References (37)

1. Strickland S, Reich E and Sherman MI: Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm. Cell 9: 231-240, 1976.
2. Ossowski L: Invasion of connective tissue by human carcinoma cell lines: requirement for urokinase, urokinase receptor, and interstitial collagenase. Cancer Res 52: 6754-6760, 1992.
3. Andreasen PA, Kristensen P, Lund LR and Dano K: Urokinasetype plasminogen activator is increased in the involuting ventral prostate of castrated rats. Endocrinology 126: 2567-2576, 1990.
4. MacKay AR, Corbit RH, Hartzler JL and Thorgeirsson UP: Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases. Cancer Res 50: 5997-6001, 1990.
5. Pollanen J, Stephens RW and Vaheri A: Directed plasminogen activation at the surface of normal malignant cells. Adv Cancer Res 57: 273-328, 1991.
6. Kwaan HC: The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev 11: 291-311, 1992.
7. Stetler-Stevenson WG, Liotta LA and Kleiner DEJ: Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 7: 1434-1441, 1993.
8. Schmitt M, Janicke F and Graeff H: Tumor-associated proteases. Fibrinolysis 6: 3-26, 1992.
9. Moller LB: Structure and function of the urokinase receptor. Blood Coagul Fibrinolysis 4: 293-303, 1993.
10. Blasi F: Surface receptors for urokinase plasminogen activator. Fibrinolysis 2: 73-84, 1988.
11. Stahl A and Mueller BM: Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Res 54: 3066-3071, 1994.
12. Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA and Levinson AD: Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci USA 90: 5021-5025, 1993.
13. Wilhelm O, Weidle U and Hohl S: Recombinant soluble urokinase receptor as a scavenger for urokinase type plasminogen activator: inhibition of proliferation and invasion of human ovarian cells. FEBS Lett 337: 131-134, 1994.
14. Peiffer J: Neuropathologie. In: Pathologie, Vol. 4. Remmele W (ed). Springer, New York, p253, 1984.
15. Yamamoto M, Sawaya R, Mohanam S, Bruner JM, Nicolson GL and Rao JS: Expression and localization of urokinase-type plasminogen activator receptor in human gliomas. Cancer Res 54: 5016-5020, 1994.
16. Gladson CL, Pijuan-Thompson V, Olman MA, Gillespie GY and Yagub IZ: Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma. Am J Pathol 146: 1150-1160, 1995.
17. Mohanam S, Sawaya R, McCutcheon I, Ali-Osman F, Boyd D and Rao JS: Modulation of in vitro invasion of human glioblastoma cells by urokinase type plasminogen activator receptor antibody. Cancer Res 53: 4143-4147, 1993.
18. Mohanam S, Chintala SK, Go Y, Bhattacharya A, Venkaiah B, Boyd D, Gokaslan ZL, Sawaya R and Rao JS: In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor. Oncogene 14: 1351-1359, 1997.
19. Go Y, Chintala SK, Mohanam S, Gokaslan Z, Venkaiah B, Bjerkvig R, Oka K, Nicolson GL, Sawaya R and Rao JS: Inhibition of in vivo tumorigenicity and invasiveness of a human glioblastoma cell line transfected with antisense uPAR vectors. Clin Exp Metastasis 15: 440-446, 1997.
20. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid quanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
21. Scatchard G: The attractions of proteins for small molecules and ions. Ann NY Acad Sci 58: 660-672, 1949.
22. Yamamoto M, Sawaya R, Mohanam S, Bindal AK, Bruner JM, Oka K, Rao VH, Tomonaga M, Nilcolson GL and Rao JS: Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Res 54: 3656-3661, 1994.
23. Nakajima M, Morikawa K, Fabra A, Bucana CD and Fidler IJ: Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst 82: 1890-1898, 1990.
24. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing principle of proteins binding. Anal Biochem 72: 248-254, 1976.
25. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
26. r 55000 form of the human plasminogen activator, urokinase. J Cell Biol 100: 86-92, 1985.
27. Estreicher A, Muhlhauser J, Carpcntier JL, Orci L and Vassalli JD: The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol 111: 783-792, 1990.
28. Mizukami IF, Garni-Wagner BA, DeAngelo LM, Liebert M, Flint A, Lawrence DA, Cohen RL and Todd RF: Immunologic detection of the cellular receptor for urokinase plasminogen activator. Clin Immunol Immunopathol 71: 96-104, 1994.
29. Bianchi E, Cohen RL, Thor AT, Todd RFR, Mizukami IF, Lawrence DA, Ljung BM, Shuman MA and Smith HS: The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res 54: 861-866, 1994.
30. Carriero MV, Franco P, Del Vecchio S, Massa O, Botti G, D'Aiuto G, Stoppelli MP and Salvatore M: Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies. Cancer Res 54: 5445-5454, 1994.
31. Pyke C, Romer J, Kallunki P, Lund L, Ralfkiaer E, Dano K and Tryggvason K: The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol 145: 782-791, 1994.
32. Kariko K, Kuo A, Boyd D, Okada SS, Cines DB and Barnathan ES: Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line. Cancer Res 53: 3109-3117, 1993.
33. Pepper MS, Sappino AP, Stocklin R, Montesano R, Orci L and Vassalli JD: Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol 122: 673-684, 1993.
34. Gyetko MR, Todd RFR, Wilkinson CC and Sitrin RG: The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest 93: 1380-1387, 1994.
35. Reiter LS, Kruithof EK, Cajot JF and Sordat B: The role of the urokinase receptor in extracellular matrix degradation by HT29 human colon carcinoma cells. Int J Cancer 53: 444-450, 1993.
36. Grondahl-Hansen J, Ralfkiaer E, Kirkeby LT, Kristensen P, Lund LR and Dano K: Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Am J Pathol 138: 111-117, 1991.
37. Langer DJ, Kuo A, Kariko K, Ahuja M, Klugherz BD, Ivanics KM, Hoxie JA, Williams WV, Liang BT, Cines DB and Barnathan ES: Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependcnt pathways. Circulation Res 72: 330-340, 1993.